Fabrication, characterization and comparison of α-arbutin loaded dissolving and hydrogel forming microneedles

[Display omitted] In this study, polyacrylic acid-co-maleic acid (PAMA) and polyvinyl alcohol (PVA) (1:4) were used to fabricate dissolving microneedles (DMNs) and hydrogel forming microneedles (HMNs) which incorporated α-arbutin. Αlpha-arbutin is commonly used as a skin lightening agent. However, i...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 586; p. 119508
Main Authors Aung, Nway Nway, Ngawhirunpat, Tanasait, Rojanarata, Theerasak, Patrojanasophon, Prasopchai, Pamornpathomkul, Boonnada, Opanasopit, Praneet
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 30.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] In this study, polyacrylic acid-co-maleic acid (PAMA) and polyvinyl alcohol (PVA) (1:4) were used to fabricate dissolving microneedles (DMNs) and hydrogel forming microneedles (HMNs) which incorporated α-arbutin. Αlpha-arbutin is commonly used as a skin lightening agent. However, it has poor penetration ability due to its hydrophilic properties. The purpose of this study was to compare the permeation of α-arbutin into the skin using DMNs and HMNs. Both types of microneedles (MNs) were sharp, strong with elegant appearance and approximately 100% penetrated the neonatal porcine skin. All needles of α-arbutin loaded DMNs were completely dissolved within 45 min, whereas maximum swelling of HMNs was observed at 4 h. In vitro permeation studies showed that α-arbutin loaded DMNs and HMNs provided significantly about 4.5 and 2.8 times, respectively, greater α-arbutin permeability than gel and commercial cream (P < 0.05). In vivo study also showed high intradermal delivery of α-arbutin levels using DMNs (5.33 µg/mL) and HMNs (1.47 µg/mL) when compared to that of commercial cream 0.15 µg/mL. Moreover, the micro-holes caused by applying MNs can reseal within 1 h. MNs were also stable at 25 °C for 3 months. The results suggested that DMNs and HMNs developed have a promising platform for transdermal delivery.
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2020.119508